BUNKER KEVIN D. (Chief Operating Officer) reported 1 transaction at ZENTALIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/21/2023ACC: 0001725160-23-000203
Officer· Chief Operating Officer
Since Apr 2020
-24.16K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
24.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.16K
Price / share
—
Trade value
—
% of position
2.8%
12/20/2023
859.09K→834.93K
Total
Net shares
−24.16K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2023 | G · Gift | −24.16K | — | — | 2.8% | 859.09K | 834.93K |
| Total | −24.16K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned15K
Common Stock
IndirectShares owned350.00
Total
15.35K indirect15.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15K | Indirect |
| Common Stock | 350.00 | Indirect |
| Total | 15.35K | 15.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported